Gordeev MF[au] - Search Results

Year	Number of Results
1997	1
1998	2
2001	1
2003	2
2005	2
2006	3
2007	1
2008	1
2014	3
2015	1
2018	1
2021	2
2022	0

1

Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity.

Wang W, Voss KM, Liu J, Gordeev MF. Wang W, et al. Among authors: gordeev mf. Chem Res Toxicol. 2021 May 17;34(5):1348-1354. doi: 10.1021/acs.chemrestox.0c00524. Epub 2021 Apr 29. Chem Res Toxicol. 2021. PMID: 33913699

2

New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.

Gordeev MF, Yuan ZY. Gordeev MF, et al. J Med Chem. 2014 Jun 12;57(11):4487-97. doi: 10.1021/jm401931e. Epub 2014 Apr 16. J Med Chem. 2014. PMID: 24694071 Review.

3

Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development.

Wu X, Meng J, Yuan H, Zhong D, Yu J, Cao G, Liu X, Guo B, Chen Y, Li Y, Shi Y, Gordeev MF, Wu J, Zhang J. Wu X, et al. Among authors: gordeev mf. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0040921. doi: 10.1128/AAC.00409-21. Epub 2021 Aug 16. Antimicrob Agents Chemother. 2021. PMID: 34398672 Free PMC article.

4

Recent developments in the identification of novel oxazolidinone antibacterial agents.

Renslo AR, Luehr GW, Gordeev MF. Renslo AR, et al. Among authors: gordeev mf. Bioorg Med Chem. 2006 Jun 15;14(12):4227-40. doi: 10.1016/j.bmc.2006.01.068. Epub 2006 Mar 9. Bioorg Med Chem. 2006. PMID: 16527486 Review.

5

Novel antibacterial azetidine lincosamides.

O'Dowd H, Lewis JG, Trias J, Asano R, Blais J, Lopez SL, Park CK, Wu C, Wang W, Gordeev MF. O'Dowd H, et al. Among authors: gordeev mf. Bioorg Med Chem Lett. 2008 Apr 15;18(8):2645-8. doi: 10.1016/j.bmcl.2008.03.032. Epub 2008 Mar 14. Bioorg Med Chem Lett. 2008. PMID: 18359228

6

Novel oxazolidinone-quinolone hybrid antimicrobials.

Gordeev MF, Hackbarth C, Barbachyn MR, Banitt LS, Gage JR, Luehr GW, Gomez M, Trias J, Morin SE, Zurenko GE, Parker CN, Evans JM, White RJ, Patel DV. Gordeev MF, et al. Bioorg Med Chem Lett. 2003 Dec 1;13(23):4213-6. doi: 10.1016/j.bmcl.2003.07.021. Bioorg Med Chem Lett. 2003. PMID: 14623004

7

In vivo antibacterial activity of MRX-I, a new oxazolidinone.

Li CR, Zhai QQ, Wang XK, Hu XX, Li GQ, Zhang WX, Pang J, Lu X, Yuan H, Gordeev MF, Chen LT, Yang XY, You XF. Li CR, et al. Among authors: gordeev mf. Antimicrob Agents Chemother. 2014;58(4):2418-21. doi: 10.1128/AAC.01526-13. Epub 2014 Jan 6. Antimicrob Agents Chemother. 2014. PMID: 24395231 Free PMC article.

8

Short-term Safety, Tolerability, and Pharmacokinetics of MRX-I, an Oxazolidinone Antibacterial Agent, in Healthy Chinese Subjects.

Wu X, Li Y, Zhang J, Zhang Y, Yu J, Cao G, Chen Y, Guo B, Shi Y, Huang J, Cao Y, Liu X, Wu J, Gordeev MF, Yuan H, Wang W. Wu X, et al. Among authors: gordeev mf. Clin Ther. 2018 Feb;40(2):322-332.e5. doi: 10.1016/j.clinthera.2017.12.017. Epub 2018 Feb 2. Clin Ther. 2018. PMID: 29398160 Clinical Trial.

9

Solid-Phase Synthesis of beta-Sultams.

Gordeev MF, Gordon EM, Patel DV. Gordeev MF, et al. J Org Chem. 1997 Nov 14;62(23):8177-8181. doi: 10.1021/jo9713316. J Org Chem. 1997. PMID: 11671928

10

Selection and characterisation of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I.

Huang Y, Xu Y, Liu S, Wang H, Xu X, Guo Q, Wu B, Gordeev MF, Wang W, Yuan Z, Wang M. Huang Y, et al. Among authors: gordeev mf. Int J Antimicrob Agents. 2014 May;43(5):418-22. doi: 10.1016/j.ijantimicag.2014.02.008. Epub 2014 Mar 22. Int J Antimicrob Agents. 2014. PMID: 24721233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results